SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

"The world still sees the core advantage Israel has and appreciates it"

Israel moves swiftly to acquire AI chips before Biden export limits take effect

Full list of Israeli high-tech funding rounds in 2025

Qbiq raises $16M Series A for its automated architectural solutions

Buzz

Most popular

Daily

Weekly

1

Orchid raises $36 million Seed round to automate enterprise identity security with AI

2

Mapping Israeli open source startups

3

Blockchain giant Chainalysis acquires Israeli startup Alterya in $150M deal

4

Israel faces AI crisis under new US export regulations

5

Israeli VCs find opportunity in adversity, betting big on 2025

Protai

2 stories about Protai

Protai Founders

Protai adds $12 million to Seed round as it aims to build oncology drug discovery pipeline

The Israeli startup, which has built a proteomics AI-based platform that comprehensively maps the course of a disease on the protein level, aims to better predict which patients will respond to a given drug as well as discover novel drug targets that were missed by genomic approaches

Kirill Pevzner and Eran Seger Protai

Protai raises $8 million in Seed for its proteomics-based platform for drug discovery

05.01.22|James Spiro

The company has developed an end-to-end AI-based platform that can map the course of a disease on the protein level